from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0090/-

LFCtreatmentdescriptionclass of inhibitor

0.543

Amikacinug/mL Amikacintranslation

0.950

Cap5-10ug/mL Capreomycintranslation

1.424

Rox10-50 ug/mL Roxithromycintranslation

0.557

SM2-5 ug/mL Streptomycintranslation

0.199

Tet5-10 ug/mL Tetracyclinetranslation

-0.395

Rif0.2-5ug/mL Rifampicintranscription

-0.181

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.219

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.026

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.580

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.747

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.169

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.195

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.027

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.461

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.876

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.464

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.325

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.718

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.556

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.523

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.458

Nigericin50 uM Nigericinrespiration

-0.203

TRC10-150 ug/mL Triclosanrespiration

-0.197

TRZ10-25 ug/mL Thioridazinerespiration

1.801

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.023

menadione6-10 ug/mL Menadionerespiration

-0.522

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.801

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.263

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.200

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.194

NRP_1Non-replicating persistence stage 1dosRassociated

-0.448

Amp0.2mg/mL AmpicillincellWall

-0.179

Cephalexin20-100 ug/mL CephalexincellWall

0.388

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.412

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.416

EMB10-20 ug/mL EthambutolcellWall

-0.251

Eta12-40 ug/mL EthionamidecellWall

-0.306

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.323

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.363

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.566

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.838

BZA0.12 mg/mL BenzamidearomaticAmides

0.114

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.314

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.259

H2O24 mM hydrogen peroxideDNAdamaging

0.018

Levo10 ug/mL LevofloxacinDNAdamaging

-0.070

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.915

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.186

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.385

UVUV-irradiationDNAdamaging

-0.032

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.438

Antimycin12.5-50 ug/mL Antimycin A?

-0.235

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.501

PA_110-50 ug/mL Antitubercular compound PA-1?

1.692

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.775

PA8240.2-2 ug/mL PA-824?

-0.649

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.153

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.126

Verapamil50 uM Verapamil?

-0.058

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.828

methoxatin10-20 ug/mL Methoxatin?